Acute Coronary Syndrome is an umbrella term that refers to a spectrum of conditions compatible with acute myocardial ischemia and/or infarction that are usually due to an abrupt reduction in coronary blood flow.
DelveInsight’s Acute Coronary Syndrome Market Insights, Epidemiology, and Market Forecast-2032 report delivers an in-depth understanding of the Acute Coronary Syndrome, historical and forecasted epidemiology as well as the Acute Coronary Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To know more about acute coronary syndrome market report offerings, click here: Acute coronary syndrome market insight
Some facts of Acute Coronary Syndrome Market are:
- According to the American Heart Association, an estimated 5–8 million patients present to the ED annually for chest pain, and 20–25% diagnosed with Acute Coronary Syndrome.
- According to a study conducted in Japan by Daida et al. (2013), ST-segment elevation myocardial infarction (STEMI) was the most frequent type of Acute Coronary Syndrome (59.4%). The vast majority (93.5%) of patients underwent percutaneous coronary intervention (PCI), with a success rate of 93.9%.
- According to available literature, males are affected more as compared to females, in the case of ACS.
- Gayle et al. (2017) stated that in 2014/15, there were 83,842 admissions to National Health Service hospitals in England and Wales, Northern Ireland, and Isle of Man with AMI as recorded in the UK national registry, Myocardial Ischaemia National Audit Project (MINAP). Of these, STEMI and NSTEMI comprised 40.5% and 59.5%, respectively. The ratio of STEMI to NSTEMI hospitalizations as recorded in MINAP has not changed over the last five years, from 1:1.50 in 2009/10 to 1:1.47 in 2014/15.
To know more about acute coronary syndrome market and epidemiology trends, click here: Acute coronary syndrom market trends
Scope of Acute Coronary Syndrome Market are
- The report covers the descriptive overview of Acute Coronary Syndrome, explaining its causes, signs and symptoms, pathophysiology, diagnosis and currently available therapies
- Comprehensive insight has been provided into the Acute Coronary Syndrome epidemiology and treatment in the 7MM
- Additionally, an all-inclusive account of both the current and emerging therapies for Acute Coronary Syndrome are provided, along with the assessment of new therapies, which will have an impact on the current treatment landscape
- A detailed review of Acute Coronary Syndrome market; historical and forecasted is included in the report, covering drug outreach in the 7MM
- The report provides an edge while developing business strategies, by understanding trends shaping and driving the global Acute Coronary Syndrome market
Request for Sample Report to get detailed info about Acute Coronary Syndrome therapies and drugs @ Acute coronary syndrome treatment market
Some of Acute Coronary Syndrome Companies are:
- Regeneron
- Sanofi
- DalCor Pharmaceutical
- CSL Behring
- AStraZeneca
- And Many Others
Request for Sample Report to get detailed info about Acute Coronary Syndrome treatment scenario and landscape @ Acute coronary syndrome companies and players
Acute Coronary Syndrome Therapies are:
- Alirocumab
- Dalcetrapib
- CSL112
- Brilinta
- And Many Others
Table of Contents:
1. Key Insights
2. Executive Summary of Acute Coronary Syndrome
3. Competitive Intelligence Analysis for Acute Coronary Syndrome
4. Acute Coronary Syndrome: Market Overview at a Glance
4.1. Acute Coronary Syndrome Total Market Share (%) Distribution in 2018
4.2. Acute Coronary Syndrome Total Market Share (%) Distribution in 2030
5. Acute Coronary Syndrome: Disease Background and Overview
6. Patient Journey
7. Acute Coronary Syndrome Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of Acute Coronary Syndrome Treatment
11. Marketed Products
List to be continued in report
12. Emerging Therapies
List to be continued in report
13. Acute Coronary Syndrome: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Acute Coronary Syndrome
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
Request for Sample Report to get detailed info about Acute Coronary Syndrome market drivers and barriers @ Acute coronary syndrome market dynamics
About Delveinsight:
DelveInsight Business Research is a leading Market Research, and Business Consultant focused purely on Healthcare. It helps pharma companies by providing them with end-to-end services to solve their business problems.
Get hold of all the Pharma and healthcare market research reports on our market research subscription-based platform PharmDelve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Ankit Nigam
Email: Send Email
Phone: +19193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/consulting